Decoding sugar functions by identifying target glycoproteins [Current Opinion in Structural Biology 2006, 16:561-566] (DOI:10.1016/j.sbi.2006.08.011);Decoding sugar functions by identifying target glycoproteins

Current Opinion in Structural Biology

Volumn 16, Issue 5, 2006, Pages 561-566

  Taniguchi, Naoyuki ^a,b   Miyoshi, Eiji ^b   Jianguo, Gu ^b   Honke, Koichi ^b   Matsumoto, Akio ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1,3(6) MANNOSYLGLYCOPROTEIN BETA 1,6 N ACETYLGLUCOSAMINYLTRANSFERASE; ALPHA 1,6 FUCOSYLTRANSFERASE; ENZYME; FUCOSE; GLYCOPROTEIN; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; N ACETYLGLUCOSAMINYLTRANSFERASE III; SUGAR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

BIOSYNTHESIS; LUNG ALVEOLUS; LUNG EMPHYSEMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TARGETING; REVIEW;

EID: 33749045903     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2006.10.009     Document Type: Erratum

References (52)

1. Lowe J.B., and Marth J.D. A genetic approach to mammalian glycan function. Annu Rev Biochem 72 (2003) 643-691. A review of the functions of glycosyltransferases in mice.
2. Freeze H.H. Genetic defects in the human glycome. Nat Rev Genet 7 (2006) 537-551. An overview of genetic defects related to the glycome.
3. Uozumi N., Yanagidani S., Miyoshi E., Ihara Y., Sakuma T., Gao C.X., Teshima T., Fujii S., Shiba T., and Taniguchi N. Purification and cDNA cloning of porcine brain GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1 → 6fucosyltransferase. J Biol Chem 271 (1996) 27810-27817
4. Yanagidani S., Uozumi N., Ihara Y., Miyoshi E., Yamaguchi N., and Taniguchi N. Purification and cDNA cloning of GDP-L-Fuc:N-acetyl-beta-D-glucosaminide:alpha1-6 fucosyltransferase (alpha1-6 FucT) from human gastric cancer MKN45 cells. J Biochem (Tokyo) 121 (1997) 626-632
5. Gu J., Nishikawa A., Tsuruoka N., Ohno M., Yamaguchi N., Kangawa K., and Taniguchi N. Purification and characterization of UDP-N-acetylglucosamine: alpha-6-D-mannoside beta 1-6N-acetylglucosaminyltransferase (N-acetylglucosaminyltransferase V) from a human lung cancer cell line. J Biochem (Tokyo) 113 (1993) 614-619
6. Nishikawa A., Ihara Y., Hatakeyama M., Kangawa K., and Taniguchi N. Purification, cDNA cloning, and expression of UDP-N-acetylglucosamine: beta-D-mannoside beta-1,4N-acetylglucosaminyltransferase III from rat kidney. J Biol Chem 267 (1992) 18199-18204
7. Dennis J.W., Laferte S., Waghorne C., Breitman M.L., and Kerbel R.S. Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 236 (1987) 582-585
8. Miyoshi E., Ihara Y., Nishikawa A., Saito H., Uozumi N., Hayashi N., Fusamoto H., Kamada T., and Taniguchi N. Gene expression of N-acetylglucosaminyltransferases III and V: a possible implication for liver regeneration. Hepatology 22 (1995) 1847-1855
9. Yamashita K., Ohkura T., Tachibana Y., Takasaki S., and Kobata A. Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. J Biol Chem 259 (1984) 10834-10840
10. Pierce M., Buckhaults P., Chen L., and Fregien N. Regulation of N-acetylglucosaminyltransferase V and Asn-linked oligosaccharide beta(1,6) branching by a growth factor signaling pathway and effects on cell adhesion and metastatic potential. Glycoconj J 14 (1997) 623-630
11. Kang R., Saito H., Ihara Y., Miyoshi E., Koyama N., Sheng Y., and Taniguchi N. Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1. J Biol Chem 271 (1996) 26706-26712
12. Ko J.H., Miyoshi E., Noda K., Ekuni A., Kang R., Ikeda Y., and Taniguchi N. Regulation of the GnT-V promoter by transcription factor Ets-1 in various cancer cell lines. J Biol Chem 274 (1999) 22941-22948
13. Miyoshi E., Nishikawa A., Ihara Y., Saito H., Uozumi N., Hayashi N., Fusamoto H., Kamada T., and Taniguchi N. Transforming growth factor beta up-regulates expression of the N-acetylglucosaminyltransferase V gene in mouse melanoma cells. J Biol Chem 270 (1995) 6216-6220
14. Saito H., Nishikawa A., Gu J., Ihara Y., Soejima H., Wada Y., Sekiya C., Niikawa N., and Taniguchi N. cDNA cloning and chromosomal mapping of human N-acetylglucosaminyltransferase V+. Biochem Biophys Res Commun 198 (1994) 318-327
15. Demetriou M., Granovsky M., Quaggin S., and Dennis J.W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409 (2001) 733-739
16. Granovsky M., Fata J., Pawling J., Muller W.J., Khokha R., and Dennis J.W. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med 6 (2000) 306-312
17. Lagana A., Goetz J.G., Cheung P., Raz A., Dennis J.W., and Nabi I.R. Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells. Mol Cell Biol 26 (2006) 3181-3193
18. Guo H.B., Lee I., Bryan B.T., and Pierce M. Deletion of mouse embryo fibroblast N-acetylglucosaminyltransferase V stimulates alpha5beta1 integrin expression mediated by the protein kinase C signaling pathway. J Biol Chem 280 (2005) 8332-8342
19. Nakahara S., Miyoshi E., Noda K., Ihara S., Gu J., Honke K., Inohara H., Kubo T., and Taniguchi N. Involvement of oligosaccharide changes in alpha5beta1 integrin in a cisplatin-resistant human squamous cell carcinoma cell line. Mol Cancer Ther 2 (2003) 1207-1214
20. Yoshimura M., Ihara Y., Matsuzawa Y., and Taniguchi N. Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J Biol Chem 271 (1996) 13811-13815
21. Ihara S., Miyoshi E., Ko J.H., Murata K., Nakahara S., Honke K., Dickson R.B., Lin C.Y., and Taniguchi N. Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching. J Biol Chem 277 (2002) 16960-16967
22. Ihara S., Miyoshi E., Nakahara S., Sakiyama H., Ihara H., Akinaga A., Honke K., Dickson R.B., Lin C.Y., and Taniguchi N. Addition of beta1-6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin. Glycobiology 14 (2004) 139-146
23. Takeuchi T., Shuman M.A., and Craik C.S. Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc Natl Acad Sci USA 96 (1999) 11054-11061
24. Lin C.Y., Anders J., Johnson M., Sang Q.A., and Dickson R.B. Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J Biol Chem 274 (1999) 18231-18236
25. Saito T., Miyoshi E., Sasai K., Nakano N., Eguchi H., Honke K., and Taniguchi N. A secreted type of beta 1,6-N-acetylglucosaminyltransferase V (GnT-V) induces tumor angiogenesis without mediation of glycosylation: a novel function of GnT-V distinct from the original glycosyltransferase activity. J Biol Chem 277 (2002) 17002-17008
26. Schachter H. Coordination between enzyme specificity and intracellular compartmentation in the control of protein-bound oligosaccharide biosynthesis. Biol Cell 51 (1984) 133-145
27. Taniguchi N., and Ihara Y. Recent progress in the molecular biology of the cloned N-acetylglucosaminyltransferases. Glycoconj J 12 (1995) 733-738
28. Nakahara S, Saito T, Kondo N, Moriwaki K, Noda K, Ihara S, Takahashi M, Ide Y, Gu J, Inohara H et al.: A novel angiogenesis inducer, β1,6-N-acetylglucosaminyltransferase V (GnT-V), is processed as a secreted enzyme by γ-secretase. FASEB J 2006, in press.
29. Sheng Y., Yoshimura M., Inoue S., Oritani K., Nishiura T., Yoshida H., Ogawa M., Okajima Y., Matsuzawa Y., and Taniguchi N. Remodeling of glycoconjugates on CD44 enhances cell adhesion to hyaluronate, tumor growth and metastasis in B16 melanoma cells expressing beta1,4-N-acetylglucosaminyltransferase III. Int J Cancer 73 (1997) 850-858
30. Yoshimura M., Ihara Y., Ohnishi A., Ijuhin N., Nishiura T., Kanakura Y., Matsuzawa Y., and Taniguchi N. Bisecting N-acetylglucosamine on K562 cells suppresses natural killer cytotoxicity and promotes spleen colonization. Cancer Res 56 (1996) 412-418
31. Yoshimura M., Nishikawa A., Ihara Y., Taniguchi S., and Taniguchi N. Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci USA 92 (1995) 8754-8758
32. Kitada T., Miyoshi E., Noda K., Higashiyama S., Ihara H., Matsuura N., Hayashi N., Kawata S., Matsuzawa Y., and Taniguchi N. The addition of bisecting N-acetylglucosamine residues to E-cadherin down-regulates the tyrosine phosphorylation of beta-catenin. J Biol Chem 276 (2001) 475-480
33. Sato Y., Takahashi M., Shibukawa Y., Jain S.K., Hamaoka R., Miyagawa J., Yaginuma Y., Honke K., Ishikawa M., and Taniguchi N. Overexpression of N-acetylglucosaminyltransferase III enhances the epidermal growth factor-induced phosphorylation of ERK in HeLaS3 cells by up-regulation of the internalization rate of the receptors. J Biol Chem 276 (2001) 11956-11962
34. Ihara Y., Sakamoto Y., Mihara M., Shimizu K., and Taniguchi N. Overexpression of N-acetylglucosaminyltransferase III disrupts the tyrosine phosphorylation of Trk with resultant signaling dysfunction in PC12 cells treated with nerve growth factor. J Biol Chem 272 (1997) 9629-9634
35. Shibukawa Y., Takahashi M., Laffont I., Honke K., and Taniguchi N. Down-regulation of hydrogen peroxide-induced PKC delta activation in N-acetylglucosaminyltransferase III-transfected HeLaS3 cells. J Biol Chem 278 (2003) 3197-3203
36. Tsuda T., Ikeda Y., and Taniguchi N. The Asn-420-linked sugar chain in human epidermal growth factor receptor suppresses ligand-independent spontaneous oligomerization. Possible role of a specific sugar chain in controllable receptor activation. J Biol Chem 275 (2000) 21988-21994
37. Gu J., and Taniguchi N. Regulation of integrin functions by N-glycans. Glycoconj J 21 (2004) 9-15. Recent findings on the role of N-glycans in the function of integrins are presented.
38. Isaji T., Gu J., Nishiuchi R., Zhao Y., Takahashi M., Miyoshi E., Honke K., Sekiguchi K., and Taniguchi N. Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration. J Biol Chem 279 (2004) 19747-19754
39. Shigeta M., Shibukawa Y., Ihara H., Miyoshi E., Taniguchi N., and Gu J. {beta}1,4-N-acetylglucosaminyltransferase III potentiates {beta}1 integrin-mediated neuritogenesis induced by serum deprivation in Neuro2a cells. Glycobiology 16 (2006) 564-571
40. Gao C.X., Miyoshi E., Uozumi N., Takamiya R., Wang X., Noda K., Gu J., Honke K., Wada Y., and Taniguchi N. Bisecting GlcNAc mediates the binding of annexin V to Hsp47. Glycobiology 15 (2005) 1067-1075
41. Iijima J., Zhao Y., Isaji T., Kameyama A., Nakaya S., Wang X., Ihara H., Cheng X., Nakagawa T., Miyoshi E., et al. Cell-cell interaction-dependent regulation of N-acetylglucosaminyltransferase III and the bisected N-glycans in GE11 epithelial cells. Involvement of E-cadherin-mediated cell adhesion. J Biol Chem 281 (2006) 13038-13046
42. Wang X., Inoue S., Gu J., Miyoshi E., Noda K., Li W., Mizuno-Horikawa Y., Nakano M., Asahi M., Takahashi M., et al. Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc Natl Acad Sci USA 102 (2005) 15791-15796. TGF-β receptor is identified as a target protein of Fut8.
43. Wang X., Gu J., Ihara H., Miyoshi E., Honke K., and Taniguchi N. Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling. J Biol Chem 281 (2006) 2572-2577
44. Li W, Nakagawa T, Koyama N, Wang X, Jin J, Mizuno-Horikawa Y, Gu J, Miyoshi E, Kato I, Honke K et al.: Down regulation of trypsinogen expression is associated with growth retardation in {alpha}1,6-fucosyltransferase-deficient mice: attenuation of proteinase-activated receptor 2 activity. Glycobiology 2006, in press.
45. Sato Y., Nakata K., Kato Y., Shima M., Ishii N., Koji T., Taketa K., Endo Y., and Nagataki S. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 328 (1993) 1802-1806
46. Okuyama N., Ide Y., Nakano M., Nakagawa T., Yamanaka K., Moriwaki K., Murata K., Ohigashi H., Yokoyama S., Eguchi H., et al. Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int J Cancer 118 (2006) 2803-2808
47. Davies J., Jiang L., Pan L.Z., LaBarre M.J., Anderson D., and Reff M. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII. Biotechnol Bioeng 74 (2001) 288-294
48. Shields R.L., Lai J., Keck R., O'Connell L.Y., Hong K., Meng Y.G., Weikert S.H., and Presta L.G. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem 277 (2002) 26733-26740
49. Shinkawa T., Nakamura K., Yamane N., Shoji-Hosaka E., Kanda Y., Sakurada M., Uchida K., Anazawa H., Satoh M., Yamasaki M., et al. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 278 (2003) 3466-3473
50. Ohtsubo K., Takamatsu S., Minowa M.T., Yoshida A., Takeuchi M., and Marth J.D. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 123 (2005) 1307-1321
51. Demetriou M., Granovsky M., Quaggin S., and Dennis J.W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409 (2001) 733-739
52. Taniguchi N. From glycobiology to systems glycobiology: international network with Japanese scientists through consortia. IUBMB Life 58 (2006) 269-272. The author provides future perspectives on the field of glycobiology.